ClinicalTrials.gg
RecruitingNCT07019727Updated Sep 30, 2025

ESSKA/ESMA ACL Injury Prevention Program in Czech Sport

An interventional study of ESSKA/ESMA 'ACL Prevention for All' methodology in Double Leg Vertical Jump (DLVJ), Single Leg Squat (SLS) and Single Leg Drop Landing (SLDL), sponsored by Masaryk University. Recruiting at 1 site in Czechia. Open to participants aged 17 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-30.

Sponsored by Masaryk University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
17 Years to 20 Years
Sex
All
01

Study summary

This study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on muscle strengthening, flexibility, coordination, proper movement techniques, and a multidisciplinary approach involving coaches, physiotherapists, and physicians. Through targeted exercise modules, education, and dynamic evaluation-including 2D motion analysis-the study seeks to reduce ACL injuries, enhance movement safety, and enable individualized training plans by identifying and correcting muscle and biomechanical imbalances.

Read the detailed description
  1. Introduction According to published data, there has been a continuous increase in ACL (anterior cruciate ligament) injuries in developed countries over the last two decades. This trend has also been observed in the Czech Republic, based on analysis conducted by our expert group. The increase is particularly notable among adolescents. Knee joint injuries subsequently lead to reduced athletic performance and, in extreme cases, can prevent a return to competitive or elite-level sport. These injuries also have significant psychosocial consequences for young athletes.

    The evidence-based program "ACL Prevention for ALL," recommended by the professional society ESSKA-ESMA for widespread implementation, has been shown to reduce the incidence of ACL injuries by 50-60% across age groups and competitive levels. The prevention concept is based on several key components:

    Muscle Strengthening and Balance: Focusing on strengthening the thigh muscles (quadriceps and hamstrings) and ensuring their balance, which plays a critical role in knee stabilization.

    Flexibility: Improving lower limb flexibility can help reduce injury risk in individuals with reduced joint mobility.

    Coordination and Proprioceptive Training: Exercises that enhance coordination and body awareness improve athletes' ability to respond quickly to movement changes, reducing injury risk.

    Movement Technique: Teaching proper techniques for jumping, landing, and changing direction is essential to reduce mechanical stress on the knees.

    Multidisciplinary Approach: Involvement of coaches, physiotherapists, and physicians in the development and implementation of prevention programs tailored to athletes' specific needs.

  2. Project Goals Reduce ACL Injury Incidence: Lower the occurrence of ACL injuries through targeted preventive exercise modules.

    Educate on Protective Movement Patterns: Teach jumping, landing, and change-of-direction techniques to minimize injury risk.

    Increase Awareness: Educate athletes, coaches, and healthcare professionals about injury risks and prevention strategies.

    Dynamic Evaluation: Regular monitoring and evaluation of program effectiveness to adapt and improve preventive measures based on current findings and results.

    The aim of the proposed research project is to develop and assess a methodology for identifying and correcting muscular imbalances and biomechanical deficiencies as part of a comprehensive ACL injury prevention program. The project will include an analysis of the effectiveness of various exercise and rehabilitation interventions, including 2D movement analysis, and their impact on muscular balance and technique. Final results and statistical data analysis will allow individualized training plans for athletes.

  3. Methodology Initial Biomechanical Assessment

    Description: Lower limb landing biomechanics will be measured using Dartfish Express (2D analysis) at the start.

    Criteria Assessed:

    Double Leg Vertical Jump (DLVJ)

    Single Leg Squat (SLS)

    Single Leg Drop Landing (SLDL)

    Drop Jump Test (DJ Test)

    Workshop Implementation

    Description: Program participants will attend a workshop led by a trained physiotherapist/conditioning coach under medical supervision. Following ESSKA/ESMA's "ACL Prevention for ALL" methodology, 12 sessions of 10 minutes each will be conducted.

    Follow-up Measurement (3 Months)

    Description: After approximately 2,000 repetitions of correct movement execution, a follow-up 2D movement analysis will be conducted.

    Evaluation: Movement analysis results will be compared to assess the program's effectiveness in pilot sports.

    Pilot Sport Selection

    Description: Based on available data, five sports with the highest ACL injury incidence will be selected for the pilot.

    Sports: Football, basketball, volleyball, handball, floorball

    Participants: 10 males and 10 females per sport

    Statistical Analysis

    Description: Collected data will be analyzed using statistical methods, including ANOVA, to assess significance.

    Six-Month Follow-up

    Description: A second follow-up after six months will assess the sustainability of preventive effects and the occurrence of new injuries.

    Control Group Comparison

    Description: A control group of 50 individuals from the selected sports will not undergo the preventive program and will be tested at the same intervals.

    Evaluation: Results will be compared to those of the intervention group to verify program effectiveness.

    This structured methodological approach enables a comprehensive evaluation of the prevention program's effectiveness, supporting project goals and improving athlete health and performance.

  4. Expected Outcomes Improved Muscle Balance and Strength: Increased balance between antagonistic muscle groups (e.g., quadriceps and hamstrings), documented via regular 2D biomechanical analyses.

    Long-term Performance Enhancement: Reduced injuries and improved biomechanics are expected to enhance overall athletic performance, measured through performance tests.

    More Effective Training Programs: Development and validation of effective and easily implementable training and rehabilitation programs, adjusted based on feedback and results.

    Increased Awareness and Knowledge: Raised awareness among athletes, coaches, and sports federation medical committees about injury risks and prevention strategies, supported by collected data.

    Reduced ACL Injury Incidence: Preventive program implementation is expected to significantly reduce ACL injury incidence in the target athlete group.

    Lower Injury Treatment Costs: Expected reduction in healthcare and rehabilitation costs due to fewer injuries.

    ACL Injury Registry and Monitoring: Establishment of a national ACL injury registry under the Czech Olympic Committee and sports federations, improving epidemiological data for program monitoring.

  5. Implementation of Results in Practice Development of Standardized Training Programs / Integration of ESSKA/ESMA Program into Routine Training

    Develop standardized training programs based on research findings that include specific exercises to enhance muscle strength, balance, and movement technique.

    Include proven preventive techniques that reduce ACL injury incidence.

    Training for Coaches and Professionals

    Organize workshops and training sessions for coaches, physiotherapists, and other sports medicine professionals to familiarize them with new methodologies and targeted training approaches.

    Provide educational materials that incorporate the latest research and recommended injury prevention practices.

    Individual Athlete Assessment

    Implement regular assessments using methods such as 2D movement analysis to identify muscular imbalances and biomechanical deficiencies.

    For athletes identified with potential risks (P4 and P5), refer to gait laboratories for 3D motion analysis.

    Customize training programs to individual athletes' needs based on assessment results.

    Education and Awareness

    Create informational materials for athletes, coaches, and sports federation medical committees on injury prevention and the importance of muscle balance and movement technique.

    Disseminate validated information through seminars, online courses, social media, or publications.

    Publish results in peer-reviewed journals and foster international collaboration with IOC and ESSKA/ESMA.

  6. Conclusion The primary objective and outcome of this project is to reduce ACL injury incidence in elite sports. A secondary objective is the protection of other knee joint structures that are frequently injured in conjunction with the ACL. Another crucial factor is the education of coaches, athletes, and healthcare personnel in prevention and proper movement techniques. Interdisciplinary collaboration-between sports medicine, physiotherapy, and coaching-is essential for effective implementation of the preventive approach.

Implemented recommendations and exercise protocols must be continuously updated based on the latest scientific evidence and practical experience. Long-term monitoring and evaluation of program effectiveness are key to ensuring success and sustainability. Based on international data, it is already evident that integrating the program into daily sports training is highly effective. The clear methodology and standardized evaluation format make it easy to implement the prevention program across all sports and age categories.

02

Conditions studied

  • Double Leg Vertical Jump (DLVJ)
  • Single Leg Squat (SLS)
  • Single Leg Drop Landing (SLDL)
  • Drop Jump Test (DJ Test)
03

In context

Lead sponsor

Masaryk University is the lead sponsor of 47 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age group: Participants aged 17-20 years

Sports activity: Individuals actively engaged in sports with a high risk of ACL injury

Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity

Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments

: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians

Exclusion criteria

Exclusion Criteria:

Current injury: Individuals with a current knee joint injury requiring treatment or surgery

Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases)

Insufficient consent: Individuals who are unable or unwilling to provide written

Irregular participation: Individuals who do not comply with regular participation in the training program or assessments

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants of the program will attend a workshop led by a trained physiotherapist or strength and conditioning coach, conducted under medical supervision. Based on the ESSKA/ESMA methodology 'ACL Prevention for All', a total of 12 five-minute exercise units will be included.

    Procedure: ESSKA/ESMA 'ACL Prevention for All' methodology

  • No intervention
    Control Group

    The control group will consist of a total of 50 individuals from selected sports in which the prevention program will not be implemented. Testing in this group will take place at the same time as in the athletes undergoing the program, with a follow-up test conducted after four months.

Interventions

  • ProcedureESSKA/ESMA 'ACL Prevention for All' methodology

    A workshop led by a trained physiotherapist/strength and conditioning coach and conducted under medical supervision. Based on the ESSKA/ESMA 'ACL Prevention for All' methodology, a total of 12 exercise units lasting 5 minutes each will be included.

06

What researchers measure

Primary outcomes

  1. Peak knee abduction moment

    The strongest predictor of ACL injury risk according to the 'ligament dominance theory' and also the most frequently reported as changed after an IPP (Injury Prevention Program). Advantage: Quantifiable, measurable using 3D analysis and force platforms, and sensitive to changes.

    Time frame: 4 months

  2. Peak knee flexion angle

    According to the 'quadriceps dominance theory,' a low angle increases the risk of ACL injury. Meta-analyses show an increase in the angle after IPP. Advantage: Easily measurable and consistently monitored in the literature.

    Time frame: 4 months

  3. Dynamic knee valgus (DKV)

    Dynamic valgus is often described as a key injury mechanism, although its measurement is more complex and less standardized. It can be supplemented with specific angles such as knee abduction angle at initial contact (IC) and medial knee displacement.

    Time frame: 4 months

Secondary outcomes

  1. Peak hip flexion angle & hip flexion at initial contact

    Lower flexion means higher vertical ground reaction force (vGRF) and lower force absorption, resulting in higher ACL load.

    Time frame: 4 months

  2. Vertical Ground Reaction Force (vGRF)

    Higher vGRF at landing correlates with increased knee loading. The effect of IPP here is debatable, but it is relevant as a secondary parameter.

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of Medicine, Masaryk University
    Brno, 62700, Czechia
    Recruiting
    • Michael Lujc, MUDr. · Contactlujc.michael@fnbrno.cz · 722101065
    • Michael Lujc, MUDr. · Principal investigator
    • Filip Hudeček, MUDr. · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2025 (actual). Primary completion is estimated for Dec 2025, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2025
First posted
Jun 13, 2025
StartActual
Jun 12, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
Sep 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07019727
Lead sponsor
Masaryk University
Collaborators
Brno University Hospital, St. Anne's University Hospital Brno, Czech Republic
Responsible party
Sponsor
First posted
Jun 13, 2025
Start date
Jun 12, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 30, 2025

Study contacts

Michael Lujc, MUDr.
Contact
lujc.michael@fnbrno.cz
722101065
Filip Huceček, MUDr.
Contact
filip.hudecek@fnusa.cz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion